05 Dec 2018 --- A new cognitive enhancing supplement coined Sophrosyne has hit the US market this month. Tapping into the booming nootropics trend, the supplement’s creators hope to reach consumers who are becoming more interested in using products that tout brain-health boosting qualities. A daily dose of Sophrosyne contains clinically active doses of 500mg of ashwagandha, 180mg of curcumin, 300mg of bacopa monnieri and 500mg of hericium erinaceus.
